Detailed answers about CROSSROADS (DUNFERMLINE) CARE ATTENDANT SCHEME, including incorporation, status, business activity, and accounts information.
When was CROSSROADS (DUNFERMLINE) CARE ATTENDANT SCHEME founded?
CROSSROADS (DUNFERMLINE) CARE ATTENDANT SCHEME was officially incorporated on 12 November 1998 and is registered under company number SC191068. Incorporation establishes the company as a legal entity registered at Companies House, allowing it to trade, enter contracts, and operate under UK company law.
What type of company is CROSSROADS (DUNFERMLINE) CARE ATTENDANT SCHEME?
PRI/LBG/NSC (Private, Limited by guarantee, no share capital, use of 'Limited' exemption). This classification indicates the legal structure of the company, which determines the way it is governed, its liability, and regulatory obligations.
What is the current status of CROSSROADS (DUNFERMLINE) CARE ATTENDANT SCHEME?
CROSSROADS (DUNFERMLINE) CARE ATTENDANT SCHEME's current status is Active. The company status indicates whether it is actively trading, dormant, or has been dissolved. Maintaining an active status is essential for legally conducting business, filing accounts, and maintaining credibility with partners and lenders.
What does CROSSROADS (DUNFERMLINE) CARE ATTENDANT SCHEME do?
CROSSROADS (DUNFERMLINE) CARE ATTENDANT SCHEME operates in the following sector: 96040 - Physical well-being activities. This provides insight into the company's primary business activity and industry focus.
What is CROSSROADS (DUNFERMLINE) CARE ATTENDANT SCHEME's registered address?
The registered office address of CROSSROADS (DUNFERMLINE) CARE ATTENDANT SCHEME is 1 EAST END, MAXTON, MELROSE, ROXBURGHSHIRE, SCOTLAND, TD6 0RL. This is the official address filed with Companies House for legal and statutory correspondence.
Is CROSSROADS (DUNFERMLINE) CARE ATTENDANT SCHEME financially stable?
The most recent accounts for CROSSROADS (DUNFERMLINE) CARE ATTENDANT SCHEME were made up to 31 March 2025, filed as MICRO ENTITY. Next accounts are due by 31 December 2026.